This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2025!
March 18-21, 2025San Diego Convention Center

Sherly Mardiana, PhD
Principal Scientist, Research/Discovery at Carisma Therapeutics


Sherly Mardiana serves as a Principal Scientist in the Research/ Discovery Group at Carisma Therapeutics, where she focuses on developing novel approaches for macrophage-based therapies in solid cancer. Sherly obtained her PhD from the University of Melbourne, Australia, with a focus on developing novel combination approaches to enhance CAR T cell efficacy in solid tumors. After completion of her PhD, Sherly spent 3 years as a postdoctoral trainee at the University of Pennsylvania under the supervision of Dr. Saar Gill. Overall, Sherly has over 10 years of experience in developing adoptive cell therapy, specializing in chimeric antigen receptor (CAR)-based T cell and macrophage therapies.

Agenda Sessions

  • Developing novel macrophage based cell therapies: CARs and beyond

  • Chairperson Remarks

  • Chairperson's Remarks

  • Chairperson's Remarks